FDA Inspection
Ascension HealthAscension Health – FDA Inspection, Nov 9, 2017
Record Details
This FDA Inspection record concerns Ascension Health, with an inspection on November 9, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dd1414d3-c897-4e82-bbdd-5551cea1c14e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031267
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ascension Health
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2026 | Not classified | Kansas City District Office | |
| July 24, 2023 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| April 10, 2014 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| February 17, 2009 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Ascension Health
- FDA Inspection 1338156 - 2026-09-24
- FDA Inspection 1210619 - 2023-07-24
- FDA Inspection 874819 - 2014-04-10
- FDA Inspection 564155 - 2009-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.